TA
Tiedemann Advisors Portfolio holdings
AUM
$2.33B
This Quarter Return
+6.08%
1 Year Return
+15.56%
3 Year Return
+31.51%
5 Year Return
+38.36%
10 Year Return
+102.1%
AUM
$2.09B
AUM Growth
+$2.09B
(+0.15%)
Cap. Flow
-$84.6M
Cap. Flow
% of AUM
-4.06%
Top 10 Holdings %
Top 10 Hldgs %
46.59%
Holding
325
New
26
Increased
70
Reduced
169
Closed
30
Top Buys
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
$20.5M |
| 2 |
LPT
Liberty Property Trust
LPT
|
$19.8M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
$18.5M |
| 4 |
Relmada Therapeutics
RLMD
|
$11M |
| 5 |
iShares Gold Trust
IAU
|
$9M |
Top Sells
Sector Composition
| 1 | Energy | 15.93% |
| 2 | Technology | 8.29% |
| 3 | Utilities | 6.16% |
| 4 | Communication Services | 3.32% |
| 5 | Financials | 2.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Southern Company
SO
$102B
| $389K | 0.02% |
6,110
-1,112
| -15% | -$70.8K |
|
227
TransDigm Group
TDG
$78.8B
| $368K | 0.02% |
658
+147
| +29% | +$82.2K |
|
228
CSX Corp
CSX
$60.6B
| $363K | 0.02% |
5,017
+178
| +4% | +$12.9K |
|
229
Industrial Select Sector SPDR Fund
XLI
$23.3B
| $363K | 0.02% |
4,457
+122
| +3% | +$9.94K |
|
230
Zoetis
ZTS
$69.3B
| $362K | 0.02% |
2,729
-694
| -20% | -$92.1K |
|
231
Astrana Health
ASTH
$1.48B
| $359K | 0.02% |
19,500
| – | – |
|
232
Edwards Lifesciences
EW
$47.8B
| $357K | 0.02% |
1,528
-494
| -24% | -$115K |
|
233
Pembina Pipeline
PBA
$21.9B
| $349K | 0.02% |
9,392
-200
| -2% | -$7.43K |
|
234
iShares US Real Estate ETF
IYR
$3.76B
| $345K | 0.02% |
3,713
| – | – |
|
235
PayPal
PYPL
$67.1B
| $341K | 0.02% |
3,146
-1,920
| -38% | -$208K |
|
236
JD.com
JD
$44.1B
| $338K | 0.02% |
9,586
| – | – |
|
237
Coastal Financial
CCB
$1.73B
| $332K | 0.02% |
20,158
-959
| -5% | -$15.8K |
|
238
BP
BP
$90.8B
| $319K | 0.02% |
8,465
-24,820
| -75% | -$935K |
|
239
iShares Floating Rate Bond ETF
FLOT
$9.15B
| $315K | 0.02% |
6,177
+846
| +16% | +$43.1K |
|
|
ENTO
240
Entero Therapeutics
ENTO
$3.61M
| $314K | 0.02% |
303,014
+239,554
| +377% | +$248K |
|
241
Novo Nordisk
NVO
$251B
| $311K | 0.01% |
5,366
-717
| -12% | -$41.6K |
|
242
Progressive
PGR
$145B
| $303K | 0.01% |
4,180
-7,813
| -65% | -$566K |
|
243
iShares US Aerospace & Defense ETF
ITA
$9.32B
| $302K | 0.01% |
1,355
-3,865
| -74% | -$861K |
|
|
RDS.A
244
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $302K | 0.01% |
5,111
-926
| -15% | -$54.7K |
|
245
Regeneron Pharmaceuticals
REGN
$61.5B
| $299K | 0.01% |
795
-22
| -3% | -$8.27K |
|
246
GE Aerospace
GE
$292B
| $297K | 0.01% |
26,658
-9,456
| -26% | -$105K |
|
247
Medtronic
MDT
$119B
| $297K | 0.01% |
2,610
-372
| -12% | -$42.3K |
|
248
iShares S&P 100 ETF
OEF
$22B
| $294K | 0.01% |
2,040
-17
| -0.8% | -$2.45K |
|
249
iShares Select U.S. REIT ETF
ICF
$1.93B
| $290K | 0.01% |
2,479
-42
| -2% | -$4.91K |
|
250
iShares Core 60/40 Balanced Allocation ETF
AOR
$2.68B
| $285K | 0.01% |
5,939
| – | – |
|